Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Med. & Reg. Officer
-
Stock Symbol
-
CPRX on Nasdaq
Gary Ingenito - trading volume in the past year for Catalyst Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Restricted Stock Units |
1.13M |
$1.28M |
$1.13 |
Feb 15, 2024 |
Direct |
Common Stock |
|
Common stock, par value $0.001 per share |
51.4K |
$927K |
$18.04 |
Aug 9, 2024 |
Direct |
|
|
Options to purchase common stock |
1.05M |
|
|
Jun 5, 2024 |
Direct |
Common Stock |
|
Options to purchase common stock |
951K |
|
|
Aug 9, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.